VSTM Q2 2018 Earnings — Verastem, Inc. Revenue & Financial Results | Market Cap Arena

VSTMVerastem, Inc.

$376M

Q2 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$10M

Gross Profit

$10M100.0% margin

Operating Income

-$18M-181.9% margin

Net Income

-$18M-183.7% margin

EPS (Diluted)

$-3.60

QoQ Revenue Growth

+Infinity%

Cash Flow

Operating Cash Flow

-$10M

Free Cash Flow

-$11M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$173M

Total Liabilities

$46M

Stockholders' Equity

$127M

Cash & Equivalents

$169M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$10M	$0	—
Gross Profit	$10M	$0	—
Operating Income	-$18M	-$13M	-35.1%
Net Income	-$18M	-$13M	-36.7%